Core Insights - The company reported a revenue of 336 million yuan and a net profit attributable to shareholders of 98.67 million yuan for the reporting period [1] - The company maintains its strategic positioning as a provider of overall solutions for minimally invasive surgical tools, focusing on business line layout and expansion [1] Financial Performance - Revenue for the reporting period was 336 million yuan, with a net profit of 98.67 million yuan [1] - R&D expenses amounted to 55.24 million yuan, reflecting an 18.79% year-on-year increase [2] R&D Investment - The number of R&D personnel increased by 19% year-on-year, indicating a strong commitment to innovation [2] - R&D investment as a percentage of revenue has grown from 11.42% in 2022 to 16.42% in 2024, demonstrating a consistent increase in focus on R&D [2] Strategic Direction - The company plans to continue its dual growth strategy of "internal development" and "external expansion" while adhering to its strategic positioning [2] - The product strategy will focus on the integration of endoscopic systems, surgical power devices, energy surgical equipment, and other extensions in the minimally invasive surgery field [2]
西山科技2024年实现营收3.36亿元 开启“内生发展”+“外延发展”双增长策略